Latest filing published 09 Feb 2016 for Aralez Pharmaceuticals Inc.. Read the official filing
No signal scores available.
John e. Barnhardt discloses dealings in 2 companies, chiefly Aralez Pharmaceuticals Inc. and Pozen Inc /NC. Between 31 December 2015 and 5 February 2016, the trades on record add up to 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 9 February 2016, reports a transaction in Aralez Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations